AKT1 and acute myeloid leukemia: In another report by Taghiloo et al. on HL-60 AML cell line, the expression of PD-L1, Gal-9, and CD155 was more effectively suppressed when the PI3K, Akt, and mTOR inhibitors were combined [8].